Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-10-04 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HERSERANGE (54440), Meurthe-et-Moselle
SELEURL PHARMACIE SAINT LOUIS : revenue, balance sheet and financial ratios
SELEURL PHARMACIE SAINT LOUIS is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HERSERANGE (54440),
this company of category PME
shows in 2022 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELEURL PHARMACIE SAINT LOUIS (SIREN 822910956)
Indicator
2024
2023
2022
2021
2020
2019
2017
Revenue
N/C
N/C
1 275 787 €
N/C
N/C
N/C
1 049 085 €
Net income
38 205 €
88 374 €
86 595 €
104 908 €
83 214 €
79 615 €
106 155 €
EBITDA
N/C
N/C
115 602 €
N/C
N/C
N/C
142 989 €
Net margin
N/C
N/C
6.8%
N/C
N/C
N/C
10.1%
Revenue and income statement
In 2024, SELEURL PHARMACIE SAINT LOUIS generates positive net income of 38 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 106 k€ -> 38 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
38 205 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
5.88%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
75.136%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELEURL PHARMACIE SAINT LOUIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
Debt ratio
247.361
93.3
60.204
50.839
28.324
10.492
5.88
Financial autonomy
21.862
43.584
51.521
55.441
64.116
71.811
75.136
Repayment capacity
3.452
None
None
None
1.555
None
None
Cash flow / Revenue
9.96%
None%
None%
None%
6.799%
None%
None%
Sector positioning
Debt ratio
5.882024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELEURL PHARMACIE SAINT L... (5.88) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
75.14%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+7 pts over 3 years
In 2024, the financial autonomy of SELEURL PHARMACIE SAINT L... (75.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
1.55 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of SELEURL PHARMACIE SAINT L... (1.55) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 196.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
196.821
Liquidity indicators evolution SELEURL PHARMACIE SAINT LOUIS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2019
2020
2021
2022
2023
2024
Liquidity ratio
166.505
219.633
214.677
205.464
196.017
184.086
196.821
Interest coverage
2.196
None
None
None
0.88
None
None
Sector positioning
Liquidity ratio
196.822024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+6 pts over 3 years
In 2024, the liquidity ratio of SELEURL PHARMACIE SAINT L... (196.82) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.88x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of SELEURL PHARMACIE SAINT L... (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELEURL PHARMACIE SAINT LOUIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
Operating WCR
33 917 €
0 €
0 €
0 €
110 879 €
0 €
0 €
Inventory turnover (days)
24
0
0
0
26
0
0
Customer payment term (days)
5
0
0
0
7
0
0
Supplier payment term (days)
41
0
0
0
40
0
0
Positioning of SELEURL PHARMACIE SAINT LOUIS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELEURL PHARMACIE SAINT LOUIS is estimated at
533 370 €
(range 371 430€ - 797 952€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
371k€533k€797k€
533 370 €Range: 371 430€ - 797 952€
NAF 5 année 2024
Valuation method used
Net Income Multiple
38 205 €
×
14.0x
=533 370 €
Range: 371 430€ - 797 952€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELEURL PHARMACIE SAINT LOUIS with other companies in the same sector:
Frequently asked questions about SELEURL PHARMACIE SAINT LOUIS
What is the revenue of SELEURL PHARMACIE SAINT LOUIS ?
The revenue of SELEURL PHARMACIE SAINT LOUIS in 2022 is 1.3 M€.
Is SELEURL PHARMACIE SAINT LOUIS profitable?
Yes, SELEURL PHARMACIE SAINT LOUIS generated a net profit of 38 k€ in 2024.
Where is the headquarters of SELEURL PHARMACIE SAINT LOUIS ?
The headquarters of SELEURL PHARMACIE SAINT LOUIS is located in HERSERANGE (54440), in the department Meurthe-et-Moselle.
Where to find the tax return of SELEURL PHARMACIE SAINT LOUIS ?
The tax return of SELEURL PHARMACIE SAINT LOUIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELEURL PHARMACIE SAINT LOUIS operate?
SELEURL PHARMACIE SAINT LOUIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart